Implantable drug delivery system becomes new kind of drug delivery system which can directly implant in the human body to optimize therapeutic properties. The needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic diseases.
This report aims to provide a comprehensive presentation of the global market for Implantable and Needle-Free Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable and Needle-Free Drug Delivery. This report contains market size and forecasts of Implantable and Needle-Free Drug Delivery in global, including the following market information:
Global Implantable and Needle-Free Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Implantable and Needle-Free Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Implantable Drug Delivery Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Implantable and Needle-Free Drug Delivery include Boston Scientific, Bayer, Medtronic, Pharmajet, Crossject, BD and Mystic Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Implantable and Needle-Free Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Implantable and Needle-Free Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Implantable and Needle-Free Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Implantable Drug Delivery
Needle-Free Drug Delivery
Global Implantable and Needle-Free Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Implantable and Needle-Free Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Implantable and Needle-Free Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Implantable and Needle-Free Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Implantable and Needle-Free Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Implantable and Needle-Free Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific
Bayer
Medtronic
Pharmajet
Crossject
BD
Mystic Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Implantable and Needle-Free Drug Delivery, market overview.
Chapter 2: Global Implantable and Needle-Free Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Implantable and Needle-Free Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Implantable and Needle-Free Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Implantable and Needle-Free Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Implantable and Needle-Free Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Implantable and Needle-Free Drug Delivery Overall Market Size
2.1 Global Implantable and Needle-Free Drug Delivery Market Size: 2022 VS 2029
2.2 Global Implantable and Needle-Free Drug Delivery Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Implantable and Needle-Free Drug Delivery Players in Global Market
3.2 Top Global Implantable and Needle-Free Drug Delivery Companies Ranked by Revenue
3.3 Global Implantable and Needle-Free Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Implantable and Needle-Free Drug Delivery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Implantable and Needle-Free Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Implantable and Needle-Free Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Implantable and Needle-Free Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Implantable and Needle-Free Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Implantable and Needle-Free Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Implantable Drug Delivery
4.1.3 Needle-Free Drug Delivery
4.2 By Type - Global Implantable and Needle-Free Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Implantable and Needle-Free Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Implantable and Needle-Free Drug Delivery Revenue, 2024-2029
4.2.3 By Type - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Implantable and Needle-Free Drug Delivery Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Implantable and Needle-Free Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Implantable and Needle-Free Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Implantable and Needle-Free Drug Delivery Revenue, 2024-2029
5.2.3 By Application - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Implantable and Needle-Free Drug Delivery Market Size, 2022 & 2029
6.2 By Region - Global Implantable and Needle-Free Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Implantable and Needle-Free Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Implantable and Needle-Free Drug Delivery Revenue, 2024-2029
6.2.3 By Region - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Implantable and Needle-Free Drug Delivery Revenue, 2018-2029
6.3.2 US Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.3.3 Canada Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.3.4 Mexico Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Implantable and Needle-Free Drug Delivery Revenue, 2018-2029
6.4.2 Germany Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.4.3 France Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.4.4 U.K. Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.4.5 Italy Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.4.6 Russia Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.4.7 Nordic Countries Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.4.8 Benelux Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Implantable and Needle-Free Drug Delivery Revenue, 2018-2029
6.5.2 China Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.5.3 Japan Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.5.4 South Korea Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.5.5 Southeast Asia Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.5.6 India Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Implantable and Needle-Free Drug Delivery Revenue, 2018-2029
6.6.2 Brazil Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.6.3 Argentina Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Implantable and Needle-Free Drug Delivery Revenue, 2018-2029
6.7.2 Turkey Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.7.3 Israel Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.7.4 Saudi Arabia Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
6.7.5 UAE Implantable and Needle-Free Drug Delivery Market Size, 2018-2029
7 Implantable and Needle-Free Drug Delivery Companies Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Company Summary
7.1.2 Boston Scientific Business Overview
7.1.3 Boston Scientific Implantable and Needle-Free Drug Delivery Major Product Offerings
7.1.4 Boston Scientific Implantable and Needle-Free Drug Delivery Revenue in Global Market (2018-2023)
7.1.5 Boston Scientific Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Implantable and Needle-Free Drug Delivery Major Product Offerings
7.2.4 Bayer Implantable and Needle-Free Drug Delivery Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Medtronic
7.3.1 Medtronic Company Summary
7.3.2 Medtronic Business Overview
7.3.3 Medtronic Implantable and Needle-Free Drug Delivery Major Product Offerings
7.3.4 Medtronic Implantable and Needle-Free Drug Delivery Revenue in Global Market (2018-2023)
7.3.5 Medtronic Key News & Latest Developments
7.4 Pharmajet
7.4.1 Pharmajet Company Summary
7.4.2 Pharmajet Business Overview
7.4.3 Pharmajet Implantable and Needle-Free Drug Delivery Major Product Offerings
7.4.4 Pharmajet Implantable and Needle-Free Drug Delivery Revenue in Global Market (2018-2023)
7.4.5 Pharmajet Key News & Latest Developments
7.5 Crossject
7.5.1 Crossject Company Summary
7.5.2 Crossject Business Overview
7.5.3 Crossject Implantable and Needle-Free Drug Delivery Major Product Offerings
7.5.4 Crossject Implantable and Needle-Free Drug Delivery Revenue in Global Market (2018-2023)
7.5.5 Crossject Key News & Latest Developments
7.6 BD
7.6.1 BD Company Summary
7.6.2 BD Business Overview
7.6.3 BD Implantable and Needle-Free Drug Delivery Major Product Offerings
7.6.4 BD Implantable and Needle-Free Drug Delivery Revenue in Global Market (2018-2023)
7.6.5 BD Key News & Latest Developments
7.7 Mystic Pharmaceuticals
7.7.1 Mystic Pharmaceuticals Company Summary
7.7.2 Mystic Pharmaceuticals Business Overview
7.7.3 Mystic Pharmaceuticals Implantable and Needle-Free Drug Delivery Major Product Offerings
7.7.4 Mystic Pharmaceuticals Implantable and Needle-Free Drug Delivery Revenue in Global Market (2018-2023)
7.7.5 Mystic Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Implantable and Needle-Free Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Implantable and Needle-Free Drug Delivery Market Drivers in Global Market
Table 3. Implantable and Needle-Free Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Implantable and Needle-Free Drug Delivery in Global Market
Table 5. Top Implantable and Needle-Free Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Implantable and Needle-Free Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Implantable and Needle-Free Drug Delivery Revenue Share by Companies, 2018-2023
Table 8. Global Companies Implantable and Needle-Free Drug Delivery Product Type
Table 9. List of Global Tier 1 Implantable and Needle-Free Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Implantable and Needle-Free Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Implantable and Needle-Free Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Implantable and Needle-Free Drug Delivery Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Implantable and Needle-Free Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Implantable and Needle-Free Drug Delivery Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Implantable and Needle-Free Drug Delivery Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Implantable and Needle-Free Drug Delivery Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 30. Boston Scientific Company Summary
Table 31. Boston Scientific Implantable and Needle-Free Drug Delivery Product Offerings
Table 32. Boston Scientific Implantable and Needle-Free Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 33. Boston Scientific Key News & Latest Developments
Table 34. Bayer Company Summary
Table 35. Bayer Implantable and Needle-Free Drug Delivery Product Offerings
Table 36. Bayer Implantable and Needle-Free Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer Key News & Latest Developments
Table 38. Medtronic Company Summary
Table 39. Medtronic Implantable and Needle-Free Drug Delivery Product Offerings
Table 40. Medtronic Implantable and Needle-Free Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 41. Medtronic Key News & Latest Developments
Table 42. Pharmajet Company Summary
Table 43. Pharmajet Implantable and Needle-Free Drug Delivery Product Offerings
Table 44. Pharmajet Implantable and Needle-Free Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 45. Pharmajet Key News & Latest Developments
Table 46. Crossject Company Summary
Table 47. Crossject Implantable and Needle-Free Drug Delivery Product Offerings
Table 48. Crossject Implantable and Needle-Free Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 49. Crossject Key News & Latest Developments
Table 50. BD Company Summary
Table 51. BD Implantable and Needle-Free Drug Delivery Product Offerings
Table 52. BD Implantable and Needle-Free Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 53. BD Key News & Latest Developments
Table 54. Mystic Pharmaceuticals Company Summary
Table 55. Mystic Pharmaceuticals Implantable and Needle-Free Drug Delivery Product Offerings
Table 56. Mystic Pharmaceuticals Implantable and Needle-Free Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 57. Mystic Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Implantable and Needle-Free Drug Delivery Segment by Type in 2022
Figure 2. Implantable and Needle-Free Drug Delivery Segment by Application in 2022
Figure 3. Global Implantable and Needle-Free Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Implantable and Needle-Free Drug Delivery Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Implantable and Needle-Free Drug Delivery Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Implantable and Needle-Free Drug Delivery Revenue in 2022
Figure 8. By Type - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2018-2029
Figure 9. By Application - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2018-2029
Figure 10. By Type - Global Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2018-2029
Figure 12. By Application - Global Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2018-2029
Figure 14. By Region - Global Implantable and Needle-Free Drug Delivery Revenue Market Share, 2018-2029
Figure 15. By Country - North America Implantable and Needle-Free Drug Delivery Revenue Market Share, 2018-2029
Figure 16. US Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Implantable and Needle-Free Drug Delivery Revenue Market Share, 2018-2029
Figure 20. Germany Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 21. France Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Implantable and Needle-Free Drug Delivery Revenue Market Share, 2018-2029
Figure 28. China Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 32. India Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Implantable and Needle-Free Drug Delivery Revenue Market Share, 2018-2029
Figure 34. Brazil Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Implantable and Needle-Free Drug Delivery Revenue Market Share, 2018-2029
Figure 37. Turkey Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Implantable and Needle-Free Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 41. Boston Scientific Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Medtronic Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pharmajet Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Crossject Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. BD Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Mystic Pharmaceuticals Implantable and Needle-Free Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
